血小板与淋巴细胞比值在心力衰竭中的作用研究进展  

Research progress on the role of platelet to lymphocyte ratio in heart failure

作　　者：托芸 尚静[1] 王瑜[1] TUO Yun;SHANG Jing;WANG Yu(Third Department of Integrated Internal Medicine,the First Affiliated Hospital of Xinjiang Medical University,Urumqi,Xinjiang 830054,China)

机构地区：[1]新疆医科大学第一附属医院综合内三科,新疆乌鲁木齐830054

出　　处：《医药前沿》2025年第10期20-22,共3页Journal of Frontiers of Medicine

摘　　要：心力衰竭是心血管疾病发展的终末阶段,严重影响患者生活质量,并给医疗部门带来巨大负担。近年来,研究发现炎症在心力衰竭的发生发展中具有重要作用。血小板与淋巴细胞比值(PLR)作为一种新型炎症标志物,已被多项研究证实与心力衰竭存在关联。本文对心力衰竭的发病机制及PLR在心力衰竭中的作用研究进展进行综述,以期为心力衰竭的临床诊治提供新思路。Heart failure is the end stage of the development of cardiovascular disease,which seriously affects the quality of life of patients and brings a huge burden to the medical department.In recent years,studies have found that inflammation plays an important role in the occurrence and development of heart failure.Platelet to lymphocyte ratio(PLR),as a novel inflammatory marker,has been associated with heart failure in several studies.This article reviews the pathogenesis of heart failure and the role of PLR in heart failure,in order to provide new ideas for the clinical diagnosis and treatment of heart failure.

关 键 词：心力衰竭 血小板 淋巴细胞 血小板与淋巴细胞比值 炎症标志物 综述 

分 类 号：R541[医药卫生—心血管疾病]